Feb 25, 2026 01:50PM
Feb 25, 2026 01:44PM
Feb 25, 2026 10:02AM
Feb 24, 2026 08:23AM
Feb 23, 2026 12:32PM
Feb 23, 2026 08:09AM
Feb 23, 2026 06:01AM Gilead to acquire Arcellx for $7.8 billion to gain control of cancer therapy
Feb 23, 2026 06:01AM
Feb 17, 2026 08:30AM
Feb 10, 2026 04:01PM
Feb 6, 2026 08:30AM
Feb 6, 2026 08:30AM
Jan 30, 2026 06:28AM
Jan 27, 2026 08:24AM Gilead Sciences (GILD) PT Raised to $145 at Truist Securities
Jan 21, 2026 05:00PM
Jan 21, 2026 05:00PM
Dec 15, 2025 08:30AM
Dec 15, 2025 08:30AM
Dec 12, 2025 10:31AM
Dec 8, 2025 02:53AM
Dec 6, 2025 02:00PM Kite Announces New Data for Pivotal iMMagine-1 Study at ASH 2025, Highlighting Anito-cel’s Opportunity in Relapsed or Refractory Multiple Myeloma
Nov 20, 2025 07:02AM
Nov 18, 2025 05:09AM
Nov 18, 2025 05:00AM
Nov 16, 2025 03:00PM
Nov 13, 2025 08:30AM
Nov 13, 2025 08:30AM
Nov 7, 2025 08:01AM GILD presents long-term data on Livdelzi for liver disease treatment
Nov 7, 2025 08:00AM
Nov 3, 2025 09:10AM
Oct 31, 2025 08:00AM
Oct 30, 2025 04:02PM
Oct 23, 2025 08:00AM
Oct 23, 2025 08:00AM
Oct 19, 2025 08:30AM Gilead to Spotlight New Virology Data Across HIV, Viral Hepatitis and Respiratory Diseases at IDWeek 2025
Oct 19, 2025 02:30AM
Oct 15, 2025 04:08AM
Oct 15, 2025 03:30AM
Sep 10, 2025 09:16AM
Sep 4, 2025 02:15PM
Sep 4, 2025 02:15PM
Aug 26, 2025 03:00AM European Commission Authorizes Twice-Yearly Yeytuo® (Lenacapavir) for HIV Prevention
Aug 21, 2025 08:30AM
Aug 21, 2025 08:30AM
Aug 7, 2025 04:02PM
Jul 25, 2025 05:58AM
Jul 25, 2025 03:00AM
Jul 14, 2025 09:31AM
Jul 14, 2025 09:30AM Gilead Presents New Data on Twice-Yearly Lenacapavir (Yeztugo®) for HIV Prevention at IAS 2025
Jul 9, 2025 08:15AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All